[go: up one dir, main page]

ATE223199T1 - Pharmazeutische zusammensetzungen mit laktobazillen zur transmucosalen verabreichung - Google Patents

Pharmazeutische zusammensetzungen mit laktobazillen zur transmucosalen verabreichung

Info

Publication number
ATE223199T1
ATE223199T1 AT97830169T AT97830169T ATE223199T1 AT E223199 T1 ATE223199 T1 AT E223199T1 AT 97830169 T AT97830169 T AT 97830169T AT 97830169 T AT97830169 T AT 97830169T AT E223199 T1 ATE223199 T1 AT E223199T1
Authority
AT
Austria
Prior art keywords
lactobacillas
pharmaceutical compositions
compositions containing
transmucosal administration
contain
Prior art date
Application number
AT97830169T
Other languages
English (en)
Inventor
Silvana Tosi
Giancarla Dondi
Original Assignee
Tosi A Farma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tosi A Farma Srl filed Critical Tosi A Farma Srl
Application granted granted Critical
Publication of ATE223199T1 publication Critical patent/ATE223199T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97830169T 1997-04-14 1997-04-14 Pharmazeutische zusammensetzungen mit laktobazillen zur transmucosalen verabreichung ATE223199T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97830169A EP0872231B1 (de) 1997-04-14 1997-04-14 Pharmazeutische Zusammensetzungen mit Laktobazillen zur transmucosalen Verabreichung

Publications (1)

Publication Number Publication Date
ATE223199T1 true ATE223199T1 (de) 2002-09-15

Family

ID=8230610

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97830169T ATE223199T1 (de) 1997-04-14 1997-04-14 Pharmazeutische zusammensetzungen mit laktobazillen zur transmucosalen verabreichung

Country Status (5)

Country Link
EP (1) EP0872231B1 (de)
JP (1) JPH10287573A (de)
AT (1) ATE223199T1 (de)
CA (1) CA2210823C (de)
DE (1) DE69715148D1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010071416A (ko) * 1998-06-05 2001-07-28 마키타 키요아키 유산균 함유 조성물, 약품 및 식품
JP4603116B2 (ja) * 1999-12-02 2010-12-22 わかもと製薬株式会社 乳酸菌含有組成物、医薬及び食品
US7214370B2 (en) 2000-12-18 2007-05-08 Probiohealth, Llc Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
KR100484480B1 (ko) * 2001-05-04 2005-04-20 정 호 김 표면 막처리된 락토바실러스 퍼멘텀 yl-3 캡슐
US20040033968A1 (en) * 2002-08-16 2004-02-19 Lin Shun Y. Optimal volume of intra-vaginal semisolid dosage forms for treating vaginal infections
CA2820023A1 (en) * 2002-09-26 2007-12-19 Vita-Herb Nutriceuticals, Inc. Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
WO2009000924A1 (en) * 2007-06-28 2008-12-31 Chr. Hansen A/S Treatment of cell suspension
US20090238796A1 (en) * 2008-03-24 2009-09-24 Tamara Vasilevna Maculevich Preparation for treatment of non-infectious inflammatory intestinal diseases
EP2158916A1 (de) * 2008-08-27 2010-03-03 Ellen Aktiebolag Milchsäurebakterien enthaltende Verabreichungseinheit
US8785183B2 (en) * 2010-09-21 2014-07-22 Biogaia Ab Active plastic material in oil
WO2014106541A1 (en) * 2013-01-04 2014-07-10 Ellen Ab Dermal composition for use in the external genital area in females
TW202334391A (zh) * 2021-10-26 2023-09-01 南韓商日東製藥股份有限公司 多個捲曲乳桿菌菌株和含有該多個菌株的用於預防或治療陰道炎的組合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK242083D0 (da) * 1983-05-27 1983-05-27 Hansens Chr Bio Syst Vaginalkapsler
US4956295A (en) * 1984-05-21 1990-09-11 Chr. Hansen's Laboratory, Inc. Stabilization of dried bacteria extended in particulate carriers
IT1227154B (it) * 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli

Also Published As

Publication number Publication date
CA2210823C (en) 2001-04-03
EP0872231B1 (de) 2002-09-04
EP0872231A1 (de) 1998-10-21
JPH10287573A (ja) 1998-10-27
CA2210823A1 (en) 1998-10-14
DE69715148D1 (de) 2002-10-10

Similar Documents

Publication Publication Date Title
FR2604090B1 (fr) Forme de dosage pharmaceutique solide comprenant au moins une unite a liberation controlee
DE68906161D1 (de) Ballon fuer medizinische einrichtung und dessen herstellung.
BR9609537A (pt) Composições farmacêuticas
ITRM910292A0 (it) Procedimento per la preparazione di elastomeri mediante l'impiego di polioli o poliammine ad elevato peso molecolare.
DE122004000023I2 (de) Pharmazeutische Zusammensetzung
DE68919146D1 (de) Ausgewählte Stämme von Lactobacillus enthaltende pharmazeutische Zusammensetzungen.
NZ306653A (en) Isolated dna il-17 receptors
ATE223199T1 (de) Pharmazeutische zusammensetzungen mit laktobazillen zur transmucosalen verabreichung
DE3863963D1 (de) Pharmazeutische zusammensetzungen.
DE69212879D1 (de) Magensaftstabile pharmazeutische Formulierungen zur Oral Verbreichung von Gallensäuren
DE3868986D1 (de) Pharmazeutische zusammensetzungen.
IL146448A0 (en) Dr4 antibodies and uses thereof
NZ224189A (en) 6-substituted 2',3'-dideoxynucleosides and pharmaceutical compositions
DE3879811D1 (de) Pharmazeutische zusammensetzung und ihre verwendung.
AU7079098A (en) Pharmaceutical composition for supressing type 2 helper t cell immune respons
IT1244471B (it) Involucro contenente cuscino d'aria
IT1226922B (it) Impianto di condizionamento dell'aria.
ATE235888T1 (de) Lyophilisiertes thioxanthenon-antitumormedikament
DE3866789D1 (de) Pharmazeutische zusammensetzungen.
IT240707Y1 (it) Struttura per l'introduzione di mezzi in pressione in assi, alberio simili
DE59107240D1 (de) Emulgatorfreie Emulsionspolymere in pharmazeutischen Zubereitungen mit verzögerter Wirkstofffreigabe und ihre Herstellung
DE3871159D1 (de) Pharmazeutische und tieraerztliche zusammensetzungen.
DE3876117D1 (de) Schwungrad fuer luftgetriebenes zahnaerztliches handstueck mit seiner intermittierenden bremse.
FR2701709B1 (fr) Forme purifiée de streptograminés, sa préparation et les compositions pharmaceutiques qui la contiennent.
MY103584A (en) 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties